Product Information |
BR-1418_PI_01.pdf
|
Registration Number |
BR-1418
|
Generic Name |
Ofatumumab
|
Brand Name |
Bonspri
|
Dosage Strength |
20 mg/ 0.4 mL
|
Dosage Form |
Solution for Injection (SC)
|
Classification |
Prescription Drug (RX)
|
Packaging |
1 mL (Net content: 0.4 mL) Type I pre-filled glass syringe with bromobutyl rubber stopper, staked needle (29 GX 12") with rigid needle shield, polypropylene plunger rod, and needle safety device in a blister tray closed with lidding paper (Box of 1's)
|
Pharmacologic Category |
Immunosuppressants
|
Manufacturer |
Novartis Pharma Stein AG (Technical Operations Schweiz, Stein Steriles)
|
Country of Origin |
Switzerland
|
Trader |
Novartis Pharma AG
|
Importer |
Novartis Healthcare Philippines, Inc.
|
Distributor |
Novartis Healthcare Philippines, Inc.
|
Application Type |
Monitored Release (MR)
|
Issuance Date |
12 September 2022
|
Expiry Date |
12 September 2027
|